Likewise, for the index of IL-17, the pooled efficacy of large and small SMD was 0.68 (95% CI: 0.14–1.23; P = 0.018), indicating that circulating IL-17 levels were slightly higher in individuals with psoriasis than in controls (Fig S2 in S1 File). This evidence concerns the gene IL17A and psoriasis.